Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Michael Steffen

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Deutsches Arzteblatt International|March 8, 2017
Inpatient OvertreatmentHans-Michael Steffen
Deutsche Medizinische Wochenschrift (1946)|December 16, 2020
[Behavioural Changes Caused by Parasites: The Parasite Manipulation Hypothesis]Hans-Michael Steffen
Drugs & Aging|July 21, 2004
Use of calcium channel antagonists for the treatment of hypertension in the elderlyHans-Michael Steffen
MMW Fortschritte Der Medizin|October 6, 2016
[Epidemiology of hypertension: Prevalence, Awareness and Treatment]Hans-Michael Steffen
Deutsche Medizinische Wochenschrift (1946)|July 17, 2019
[Gut Microbiome and Cardiovascular Disease]Hans-Michael Steffen, Münevver Demir
Journal of Digestive Diseases|September 26, 2015
Nonalcoholic fatty liver disease - current status and future directionsMünevver Demir, Sonja Lang, Hans-Michael Steffen
Deutsche Medizinische Wochenschrift (1946)|April 1, 2016
[Non-alcoholic fatty liver disease--What's new]Elke Roeb, Hans-Michael Steffen, Jörg Bojunga
Journal of Human Hypertension|July 11, 2025
Detection of masked hypertension in patients with metabolic-dysfunction associated steatotic liver disease using a novel clinical risk modelPhilipp Kasper, Münevver Demir, Hans-Michael Steffen
Deutsche Medizinische Wochenschrift (1946)|August 20, 2021
[Cirrhotic cardiomyopathy]Philipp Kasper, Hans-Michael Steffen, Guido Michels
Journal of Hepatology|July 14, 2025
Optimize hypertension management to tackle the CVD burden in MASLDPhilipp Kasper, Münevver Demir, Hans-Michael Steffen
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Deutsches Arzteblatt International|March 8, 2017
Inpatient OvertreatmentHans-Michael Steffen
Deutsche Medizinische Wochenschrift (1946)|December 16, 2020
[Behavioural Changes Caused by Parasites: The Parasite Manipulation Hypothesis]Hans-Michael Steffen
Drugs & Aging|July 21, 2004
Use of calcium channel antagonists for the treatment of hypertension in the elderlyHans-Michael Steffen
MMW Fortschritte Der Medizin|October 6, 2016
[Epidemiology of hypertension: Prevalence, Awareness and Treatment]Hans-Michael Steffen
Deutsche Medizinische Wochenschrift (1946)|July 17, 2019
[Gut Microbiome and Cardiovascular Disease]Hans-Michael Steffen, Münevver Demir
Journal of Digestive Diseases|September 26, 2015
Nonalcoholic fatty liver disease - current status and future directionsMünevver Demir, Sonja Lang, Hans-Michael Steffen
Deutsche Medizinische Wochenschrift (1946)|April 1, 2016
[Non-alcoholic fatty liver disease--What's new]Elke Roeb, Hans-Michael Steffen, Jörg Bojunga
Journal of Human Hypertension|July 11, 2025
Detection of masked hypertension in patients with metabolic-dysfunction associated steatotic liver disease using a novel clinical risk modelPhilipp Kasper, Münevver Demir, Hans-Michael Steffen
Deutsche Medizinische Wochenschrift (1946)|August 20, 2021
[Cirrhotic cardiomyopathy]Philipp Kasper, Hans-Michael Steffen, Guido Michels
Journal of Hepatology|July 14, 2025
Optimize hypertension management to tackle the CVD burden in MASLDPhilipp Kasper, Münevver Demir, Hans-Michael Steffen
Pageof 9